Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine About Us Budget'26 Budget'24
  • Budget'25 Budget'24
    • Home
    • News

    IREDA shares are listed at a 56% premium to the IPO price


    Finance Outlook India Team | Wednesday, 29 November 2023

    IREDA increased its gains by 11.4% to Rs 55.7 from its initial public offering price of Rs 50. At the same time, the stock was up 74% from its IPO price. Prior to the listing, the company's shares traded in the unlisted market at a premium of Rs 12.25. Investors responded enthusiastically to the IPO, which was 38.8 times oversubscribed, showing investor confidence in the company's solid fundamentals and development prospects.

    Analysts feel that India has lofty renewable energy aspirations, and that IREDA, as the largest green financing NBFC, is best positioned to capitalize on the fast rising sector growth.

    "We believe the listing premium is justified on the back of the company being tagged as a leading PSU player in renewable energy financing and advisory services and a possible upgradation from a Mini Ratna to a Navratna company in the near future which increases financial autonomy, allowing it to accelerate faster in the competition," said Prashanth Tapse, CEO of Mehta

    The proceeds of the new issuance will be utilized to supplement its capital base in order to satisfy future capital requirements and to fund future lending. IREDA has an exceptional track record of nurturing and providing financial assistance for fresh and sustainable energy (RE) projects, as well as energy efficiency and conservation (EEC) efforts, spanning over 36 years.

    The company is India's largest non-banking financial company (NBFC) committed to green financing. Its outstanding term loan portfolio stood at Rs 47,206 crore as of June 2023, indicating its diversified investment operations. The company's portfolio is geographically diverse, with term loans outstanding in 23 states and five union territories. Revenue climbed 47% to Rs 2,320 crore in the half year ending September 2023, while profit increased 41% to Rs 579 crore.

    The company's standalone revenue from operations climbed 22% to Rs 3,482 crore in FY23, owing mostly to an increase in term loans outstanding. In the same quarter, net profit increased 36% to Rs 865 crore. For FY23, the capital to risk-weighted asset ratio (CRAR) was 18.82%, and for the June quarter, it was 19.95%.


     



    Read More:

    ConvoZen Launches End-to-End Conversational AI

    India & France Revise Tax Treaty, Scrap MFN Clause, Ease Dividends

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe WRAPUP’25